1.94

3.74% +0.07

Monogram Orthopaedics Inc (MGRM)

Overview News Price History Financials Discussions Forecast

Monogram Orthopaedics Inc stock is currently priced at $1.94, with a 24-hour trading volume of 63,127. It has seen a +3.74% increased in the last 24 hours and a -16.74% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $1.90 pivot point. If it approaches the $1.98 resistance level, significant changes may occur.

Previous Close:

$1.87

Open:

$1.84

24h Volume:

63,127

Market Cap:

$61.42M

Revenue:

Net Income/Loss:

$-13.20M

P/E Ratio:

-3.2296

EPS:

-0.6007

Net Cash Flow:

$-12.14M

1W Performance:

-20.26%

1M Performance:

-16.74%

6M Performance:

-30.71%

1Y Performance:

+0.00%

1D Range:

$1.84

$1.97

52W Range:

$1.53

$4.90

Monogram Orthopaedics Inc Stock (MGRM) Company Profile

Name

Monogram Orthopaedics Inc

Sector

Healthcare (1213)

Industry

Medical Devices (160)

Phone

512 399 2656

Address

3913 Todd Lane, Suite 307, Austin

Employee

Twitter

Next Earnings Date

Latest SEC Filings

MGRM's Discussions on Twitter

Monogram Orthopaedics Inc Stock (MGRM) Latest News

Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga

Dow Dips 200 Points; Citigroup Posts Upbeat Earnings

Benzinga

Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket

Benzinga

Monogram Orthopaedics Inc Stock (MGRM) Financials Data

Monogram Orthopaedics Inc (MGRM) Net Income 2024

MGRM net income (TTM) was -$13.20 million for the quarter ending September 30, 2023.

Monogram Orthopaedics Inc (MGRM) Cash Flow 2024

MGRM recorded a free cash flow (TTM) of -$12.14 million for the quarter ending September 30, 2023.

Monogram Orthopaedics Inc (MGRM) Earnings per Share 2024

MGRM earnings per share (TTM) was -$0.5254 for the quarter ending September 30, 2023.

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.